Unknown

Dataset Information

A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.


ABSTRACT: We are in the midst of the global pandemic. Though acute respiratory coronavirus (SARS-COV2) that leads to COVID-19 infects people of all ages, severe symptoms and mortality occur disproportionately in older adults. Geroscience interventions that target biological aging could decrease risk across multiple age-related diseases and improve outcomes in response to infectious disease. This offers hope for a new host-directed therapeutic approach that could (i) improve outcomes following exposure or shorten treatment regimens; (ii) reduce the chronic pathology associated with the infectious disease and subsequent comorbidity, frailty, and disability; and (iii) promote development of immunological memory that protects against relapse or improves response to vaccination. We review the possibility

SUBMITTER: Justice JN 

PROVIDER: S-EPMC7479299 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature